CCBIO905 – Methods in Cancer Biomarker Research
This course has focus on the full panel of advanced and standard methods with relevance for cancer biomarkers. The intention is a methodological course that also includes components of ethics and economy.
The thematic parts include methods ranging from basic techniques on nucleotides and proteins to more advanced approaches, as well as bioinformatics and biobanking supplemented by presentations on ethics and economics of cancer biomarkers.
The course will focus on methods to study tissue samples, blood samples, urin samples, and other biologic materials, like immunohistochemistry, in situ hybridization, PCR-techniques and sequencing, Western blot and ELISA, microarray methods, proteomics, circulating tumor cells and DNA, flow cytometry, bioinformatics and biobanks. Changes in nucleic acids and proteins in different settings will be covered.
The students are acquired prepare group presentations on important scientific papers describing results from clinical trials that have led to approval of new cancer treatments. The presentations should address topics like the studies’ background, drug mechanisms, the methods and impact of the biomarkers reported in terms of predictive power, and the trials’ clinical results.
The course concludes with a three-hour multiple-choice examination.
Responsible for the course: Lars A. Akslen and Jim Lorens have the academic responsibility and Ingeborg Winge is the course coordinator.
Who can attend: The course open to researchers, postdocs, students (PhD, master, students in the Medical Student Research Program) and others who are interested. In case of fully booked, CCBIO-affiliated students will have priority.
Registration: You can register on this registration form. Registration deadline is August 20th at noon.
Place: Haukeland University Hospital, main building: Birkhaugsalen (D303) day 1, and Aud. 4 at BB-building day 2 and 3.
When: August 27-29, 2018
Course contact: Ingeborg.firstname.lastname@example.org
Program: Please find program on this link.